A detailed history of Charles Schwab Investment Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 175,595 shares of NVO stock, worth $20.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
175,595
Previous 128,069 37.11%
Holding current value
$20.4 Million
Previous $16.4 Million 52.42%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $5.83 Million - $6.98 Million
47,526 Added 37.11%
175,595 $25.1 Million
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $3.42 Million - $4.56 Million
33,525 Added 35.46%
128,069 $16.4 Million
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $2.29 Million - $2.75 Million
26,067 Added 38.07%
94,544 $9.78 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $4.43 Million - $9.71 Million
48,678 Added 245.86%
68,477 $6.23 Million
Q2 2023

Aug 09, 2023

BUY
$155.98 - $172.65 $1.28 Million - $1.42 Million
8,212 Added 70.87%
19,799 $3.2 Million
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $650,318 - $782,013
4,914 Added 73.64%
11,587 $1.84 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $684,316 - $903,057
6,673 New
6,673 $903,000
Q3 2021

Nov 16, 2021

SELL
$84.42 - $106.62 $3.75 Million - $4.74 Million
-44,467 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$67.66 - $84.76 $4.35 Million - $5.45 Million
-64,343 Reduced 59.13%
44,467 $3.73 Million
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $4.45 Million - $5.03 Million
-66,312 Reduced 37.87%
108,810 $7.34 Million
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $3.77 Million - $4.36 Million
59,024 Added 50.84%
175,122 $12.2 Million
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $6.17 Million - $6.8 Million
96,806 Added 501.79%
116,098 $8.06 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $2.43 Million - $2.82 Million
-41,443 Reduced 68.24%
19,292 $1.26 Million
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $94,369 - $123,600
-1,908 Reduced 3.05%
60,735 $3.66 Million
Q4 2019

Feb 07, 2020

SELL
$49.86 - $58.26 $3.36 Million - $3.92 Million
-67,345 Reduced 51.81%
62,643 $3.63 Million
Q3 2019

Nov 08, 2019

SELL
$47.54 - $53.43 $7.97 Million - $8.95 Million
-167,547 Reduced 56.31%
129,988 $6.72 Million
Q2 2019

Aug 09, 2019

BUY
$46.79 - $52.47 $13.9 Million - $15.6 Million
297,535 New
297,535 $15.2 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $263B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.